Indication
Herpes zoster
7 clinical trials
12 products
Clinical trial
A PHASE 1/2 RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST VARICELLA ZOSTER VIRUS IN HEALTHY INDIVIDUALSStatus: Recruiting, Estimated PCD: 2025-12-20
Product
ShingrixProduct
PF-07915234Product
PF-07915234: VZV modRNAProduct
PF-07921188Product
PF-07921186Product
Selected Vaccine CandidateProduct
CRV-101Clinical trial
A Randomized, Observer-Blind, Phase 2 Study To Assess the Safety and Immunogenicity of CRV-101 Vaccine Head-To-Head With SHINGRIX® for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderStatus: Active (not recruiting), Estimated PCD: 2024-10-04
Clinical trial
A Phase 1 Randomized, Double-Blinded, Active-Controlled, 2-Dose Study to Assess the Safety and Immunogenicity of a Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects 50 to 69 Years of Age.Status: Active (not recruiting), Estimated PCD: 2024-02-23
Product
Active ControlProduct
JCXH-105Product
Z-1018Clinical trial
A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 YearsStatus: Completed, Estimated PCD: 2022-10-20
Clinical trial
Systems Biology of Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)Status: Completed, Estimated PCD: 2023-04-03
Product
Shingrix®Clinical trial
Phase II, Non-randomized, Open-label Study to Assess the Immunogenicity and Clinical Efficacy of the Recombinant Zoster Vaccine for Recipients of an Allogeneic Hematopoietic Stem Cell TransplantStatus: Recruiting, Estimated PCD: 2025-03-07
Clinical trial
Immunogenicity of the Recombinant Zoster Vaccine (Shingrix ®) in Multiple Sclerosis Patients Treated With Anti-CD20 Antibodies Compared to Controls- a Phase IV Monocentric StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Recombinant Zoster Vaccine